Missing/wrong data?
Log in to edit
Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation
scientific article published in March 2011
Author/s
author: Kinga Malottki, David Moore, Olalekan A. Uthman
Work details
Publication date
March 1, 2011
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.